Objective: Although activation of protein kinase C (PKC) modulates the function of normal cardiac myocytes and likely plays a role in the pathogenesis of cardiomyopathic disease states, the molecular basis of PKC expression in human ventricle has not been examined in detail. Methods: We have performed Western analysis and immunohistochemistry on explanted human cardiac tissue from nondiseased and diseased specimens using isoform-specific antibodies directed against all known PKC isozymes. Results: In homogenates from left and right ventricle, all isoforms except PKC-g and u were detected by immunoblotting, with confirmation using a second antibody directed against a different epitope when possible. For PKC-bII, d, and´, data indicated that these isoforms were variably phosphorylated in vivo, resulting in multiple bands during immunoblotting. Because of potential antibody cross-reactivity, reverse transcriptase polymerase chain reaction (RT-PCR) was performed which confirmed expression of PKC-a, bI, and z. Immunohistochemistry demonstrated that all isoforms detected in ventricular homogenate by Western analysis could be localized to cardiac myocytes. From a methodologic standpoint, significant degradation of PKC isoforms could be demonstrated when samples were either frozen or allowed to remain at room temperature, compared to immediate subcellular fractionation. Conclusions: These findings indicate that the PKC expression in human ventricular myocytes is remarkably diverse, with multiple conventional, novel, and atypical isoforms present, and highlight the importance of sample preparation in comparative studies of PKC isoform expression.
Introduction
trophy [3, 5, 6] , ischemia and ischemic preconditioning [7, 8] , and heart failure [9, 10] , based on numerous studies Protein kinase C (PKC) is a family of serine / threonine using animal models. kinases which play a major role in signal transduction in It is now recognized that PKC comprises a group of at the heart. In response to circulating hormones such as least 11 different isoforms which can generally be divided norepinephrine, endothelin, and angiotensin II, activation into three categories [2, 4, 11] : calcium-dependent or conof PKC triggers a multitude of intracellular events, includventional (c) PKCs (a, bI, bII, and g); calcium-indepening phosphorylation of cardiac structural elements, stimudent or novel (n) PKCs (d,´, h, and u); and atypical (a) lation of other proteins such as kinases, and altered gene PKCs (z and l / i) which are unresponsive to phorbol expression [1] [2] [3] [4] . These events can influence multiple esters. The most recently-described isoform, PKC-m, is physiologic processes in the heart, including contraction, structurally distinct with homology to the protein kinase D relaxation, and chronotropy [3, 5, 6] . PKC activation has family. Substantial experimental evidence indicates that also been implicated in the pathophysiology of a number individual PKC isoforms differ with respect to tissue of cardiovascular disease states [1, 3] , including hyperdistribution and subcellular localization, as well as substrate specificity [3, [12] [13] [14] [15] . Such data has led to speculation of isoform-specific functions in vivo [14] [15] [16] [17] [18] . The recent development of isoform-specific PKC inhibitors and diuretics (7) . Following explantation, specimens were should delineate the role of individual isozymes in physioquickly immersed into ice-cold cardioplegic solution and logic and disease processes [17, 19, 20] . As an example, the transported immediately for subcellular fractionation. spontaneous rate of contraction of neonatal rat cardiac myocytes can be inhibited by activation of PKC-´but not 2.2. Preparation of subcellular fractions a, b, d, or z [17] . The potential therapeutic use of selective PKC inhibitors is currently under active investigation Portions of the left and right ventricular free walls were [19, 20] .
dissected and minced into small pieces of approximately Although previous studies have investigated PKC ex-232 mm. Subcellular fractionation was performed at 48C pression in cardiac tissue from various mammalian species using approximately 2-3 g of tissue, while the remainder [1, 9, 10, 13, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , the isoforms which reside in human was immediately frozen in liquid nitrogen until processed. heart have not been determined in detail. In rat heart, Tissue was homogenized in a buffer (mM: Tris-HCl 25, several reports have suggested that a limited repertoire of EDTA 2, EGTA 0.5, PMSF 1, DTT 1, pefebloc 0.5, PKC isoforms are present in enzymatically isolated adult benzamide 1, iodoacetamide 1, 1,10-phenanthrolene 1, rat ventricular myocytes, and that detection of additional aprotinin 0.004, leupeptin 0.2, pepstatin A 0.0015, and isoforms in tissue homogenates may result from contamibacitracin 0.7). The homogenate was separated into soluble nation by non-myocyte elements [21, 22, 24] . However, and particulate fractions by centrifugation at 50 0003g for recent results examining a limited number of isoforms in 10 min, subjected to a protein assay (BCA Protein Assay human heart suggest that expression in this species may be Reagent, Pierce, Rockford, IL), diluted in 23 sodiummore diverse [31] . In this study, we have undertaken a dodecyl-sulfate (SDS) sample buffer, aliquoted, and stored comprehensive investigation of PKC expression in exat 2808C until use. planted human ventricle using Western analysis and imRat brain cellular extracts were prepared for use as a munohistochemistry with multiple isoform-specific antipositive control during Western blot analysis for PKC bodies directed against each of the PKC isoforms identified isoforms a, bI, bII, g, d,´, z and i. The use of rats in this to date. Our results indicate that the molecular basis of investigation was in accordance with the Guide for the PKC expression in human heart is complex, with identifiCare and Use of Laboratory Animals published by the US cation of nearly all isoforms in ventricular myocytes.
National Institutes of Health (NIH Publication No. 85-23, revised 1996). Adult Sprague-Dawley rats were anesthetized by intraperitoneal injection of ketamine (80 mg / 2. Methods kg), decapitated, and the entire brain rapidly harvested. Tissue was rinsed with phosphate-buffered saline (PBS), 2.1. Patient population minced, and subjected to subcellular fractionation as described above for human heart. Tissue was obtained from five nondiseased human hearts, four of which were rejected as donor hearts for 2.3. Selection of antibodies for Western blot analysis cardiac transplantation, as well as one autopsy specimen, in accordance with the principles outlined in the DeclaraBecause antibodies from different companies demontion of Helsinki (Cardiovascular Research 1997;35:2-3). strated substantial differences in sensitivity to detect a The subjects were 14-67 years of age (all females), and given PKC isoform, a systematic comparison was underthe causes of death included trauma (1), intracranial taken initially between polyclonal antibodies from multiple hemorrhage (2), smoke inhalation (1), and bowel infarcsources (typically GibcoBRL, Santa Cruz, Research & tion in one. Four subjects were receiving dopamine at the Diagnostics, and Calbiochem) using recombinant PKC time of organ harvest; additional intravenous agents inisoforms or other positive controls, in order to identify the cluded nitroprusside in two, phenylephrine in one, and most sensitive and specific antibodies for Western analysis. norepinephrine in one. In all cases, the left and right
The initial antibody dilutions tested were based on the ventricles were normal by visual inspection and the manufacturer's recommendations and previous reports in coronary arteries were widely patent. There was no history the literature, with final concentrations determined by of cardiac disease in any individual. Tissue from abnormal testing a range of dilutions with appropriate positive cardiac specimens was obtained following explant for controls. Based on these results, two antibodies were cardiac transplantation (n57). All patients had class III-IV chosen, directed against unique, non-overlapping epitopes congestive heart failure due to ischemic cardiomyopathy when possible, for detection of each PKC isoform in tissue (ages 43-61, all male). Six patients were hospitalized in (Table 1) . Antibodies against the most recently described the cardiac intensive care unit at the time of transplanta-PKC isoforms (PKC-u, i and m) were available from a tion. Medications prior to transplant included dopamine / more limited number of commercial sources. In some dobutamine (6) , phosphodiesterase inhibitors (3), ancases, monoclonal antibodies were used when polyclonal giotensin converting enzyme inhibitors (4), digoxin (7), antibodies were either inadequate or unavailable for West- Table 1 clonal, affinity-purified goat antibody for PKC-u (1:500); Approximately 1-2 mg of left ventricle was used to ern analysis. A PKC isoform was scored as present if both extract total RNA using a modified single step extraction antibodies recognized bands of similar molecular mass, procedure [32] . The sample was incubated with RNAsewith loss of immunoreactivity following peptide block for free DNase, and cDNA was reverse transcribed (RT) each polyclonal antibody.
according to the manufacture's instruction (First-strand cDNA synthesis Kit, Pharmacia, Piscataway, NJ). PKC 2.4. Western blot analysis sequences were amplified by using the polymerase chain reaction (PCR) and isoform-specific primers: for PKC-a: Fifty mg of human heart protein was diluted with SDS forward 59 CGA CTG TCT GTA GAA ATC TGG 39 (nt sample buffer, boiled for 2 min, and immediately loaded 742-762), reverse 59 CAC CAT GGT GCA CTC CAC into lanes of a 6-10% SDS-polyacrylamide gel. A posi-GTC 39 (nt 1185-1165); for PKC-bI: forward 59 CTG tive control was also loaded for each blot; as noted above TGG AAC TGA CTC CCA CTG 39 (nt 2134-2154), for most isoforms, this was rat brain soluble protein (0.5-reverse 59 ATA CTG AAG CAT TTT GGT ATC 39 (nt 1.5 mg); for PKC-h, u and m, 50-100 mg of particulate 2538-2518); for PKC-z: forward 59 AGG AAG CTG TAC protein from EL4 cells, whole cell lysate from a lymphoma CGT GCC AAC 39 (nt 349-369), reverse 59 CTT TAA cell line (Jurkat cells), and mouse kidney homogenate were TGC TGT CAT GCT TCC GG 39 (nt 659-637). Primers 1 used, respectively. Proteins were separated by SDS-polyfor the human cardiac Na channel, hH1, were used as a acrylamide gel electrophoresis (PAGE) and transferred to a positive control for each PCR reaction. DEPC water was polyvinylidene difluoride (PVDF) membrane by a semiused in place of primers as a negative control. PCR dry transfer cell apparatus (Bio-Rad, Hercules, CA).
amplification was performed with 35 cycles and a denaturMembranes were incubated in 5% nonfat dry milk in ing temperature of 948C for 30 s, annealing temperature of TBST solution (mM: Tris-base 10, NaCl 150, Tween-20 588C for 30 s (for PKC-bI, 608C), and extension tempera-0.1%, pH 7.6) for at least 2 h at room temperature, ture of 728C for 1 min. PCR products (10 ml) were loaded followed by incubation with primary antibody in TBST at onto 1.5% agarose gel, stained with ethidium bromide and 48C overnight. Most antibodies selected for Western analyvisualized under UV light. sis were polyclonal, affinity-purified rabbit IgG from either Santa Cruz (Santa Cruz, CA) or GibcoBRL (Grand Island, 2.6. Dephosphorylation of PKC isoforms NY), as shown in Table 1 . For Santa Cruz antibodies, the following dilutions were used: PKC-a 1:5000; PKC-bI, d, Dephosphorylation of PKC isoforms was stimulated by and h 1:1000; PKC-bII 1:2000; and PKC-z, i, u and m warming 50 mg of soluble or particulate protein to 308C 1:500. For GibcoBRL antibodies, the dilutions used were:
for 60 min. This permitted activation of endogenous PKC-a, d and z 1:500; PKC-bI, bII,´, and h 1:250.
phosphatases present in human heart, and dephosphorylaAdditional antibodies used included: Research & Diagnostion achieved in this manner was as efficient as the tics (Berkeley, CA) for PKC-g (1:500); Santa Cruz polyaddition of exogenous phosphatases (PP) including PP1 or 32 PP2A (data not shown).
[ P]glycogen phosphorylase a remaining three isoforms, underwent immunostaining was used as a positive control, with a reduction in using the method described below for human heart secradioactivity indicative of dephosphorylation (with convertions. sion to glycogen phosphorylase b). To terminate the To determine PKC isoform expression in human left reaction, 23 SDS sample buffer was added. In some ventricle, sections mounted on slides were allowed to reactions, dephosphorylation was inhibited using a combire-hydrate by extensive washing with 50-100% ethanol nation of phosphatase inhibitors, including (mM): NaF 10, and xylene solution. Sections were further washed and b-glycerophosphate 10, Na pyrophosphate 100, Na orthoincubated with a blocking solution (e.g. 10% goat serum in vanadate 2.5, and microcystine 1. All samples were boiled 1% bovine-serum albumin (BSA) / PBS) for at least 1 h at 2 min prior to loading onto a 6% gel for Western analysis.
room temperature followed by the addition of primary antibody (e.g. diluted in 1% BSA / PBS with 1% goat 2.7. Preparation of tissue sections serum) and incubation overnight at 48C in a humidified chamber. Dilution of the antibodies for PKC-a, bI, bII, d, For human heart, a small piece of left ventricle (333 z, and h was 1:100; for PKC-g,´, u, i, and m, 1:50. mm) was dissected from the heart, immersed in 4%
Pre-immune rabbit serum at 1 mg / ml was used as a paraformaldehyde solution at 48C overnight, dehydrated negative control. Sections were washed three times with with 50-100% ethanol, and embedded into paraffin wax.
PBS and incubated with alkaline phosphatase-conjugated The tissue was sliced into 7-mm thick sections using a secondary antibody for 1 h at room temperature followed microtome and baked at 558C overnight. Slides were by three washes with PBS. Detection was achieved using stored at 48C until processed for immunohistochemistry.
fast naphthol-red as the enzyme substrate and was termiRat brain was used as a positive control for immunonated by washing with PBS. Sections were counter-stained histochemistry for most PKC isoforms [33] [34] [35] . Rats were with hematoxylin (Anatech, Battle Creek, MI) for 60 s, anesthetized with intraperitoneal pentobarbital and transwashed, air dried, and covered with Aquamount (Lerner cardially perfused with 1 l of 4% paraformaldehyde. The Laboratories, Pittsburgh, PA) and a coverslip. The spebrain was removed and immersed in cold 30% sucrose cificity of polyclonal antibody detection for each isoform overnight at 48C. The cerebellum was dissected, frozen to was determined using pre-absorption of the antibody by a microtome stage with dry ice and sectioned at 40 mm incubation with a 10-fold excess of specific epitope thickness. Sections were collected in 0.05 M Tris-saline peptide. solution (pH 7.6) and stored either in Tris-saline at 48C or in antifreeze solution (30% ethylene glycol, 30% glycerol in sodium phosphate buffer) at 2208C until processed for 3. Results immunohistochemistry. As noted below, Jurkat cells were also used as positive control for some PKC isoforms. Cells 3.1. PKC isoforms in normal human ventricle: Western were collected onto a slide by cytocentrifugation, air-dried, analysis and fixed in 4% paraformaldehyde immediately prior to immunohistochemistry.
Initial studies were conducted to determine which PKC isoforms were expressed in nondiseased human left ventri-2.8. Immunohistochemistry cle using immunoblotting. Total ventricular homogenate was subjected to subcellular fractionation to obtain soluble Based on the results of Western blot analysis, primary (S) and particulate (P) fractions (n55 and n57 for antibodies from Santa Cruz were used in these experiments nondiseased and diseased hearts, respectively). These except for PKC-g,´, u, i (Transduction), and m (Calbiochfractions were then analyzed by Western blotting using the em). Initially, the sensitivity of each of these antibodies antibodies in the first column of Table 1 . The results for was determined with positive controls using a range of two nondiseased specimens (ND1, ND2) are shown for the concentrations, with peptide block to assess the specificity conventional PKC isoforms in Fig. 1 , the novel PKCs in of immunodetection. While rat brain cerebellar sections Fig. 2 , and atypical isoforms plus PKC-m in Fig. 3 (left were used as a positive control for most antibodies, Jurkat side of each figure) . For all isoforms except PKC-g and u, cells concentrated by cytocentrifugation on a microscope one or more bands was detected having a molecular mass slide served this purpose for PKC-u, i, and m. Immunothat correlated with previously-published values for inhistochemistry of rat brain cerebellum was performed dividual PKC isoforms [1, 22, 24, [37] [38] [39] . Most isoforms using methods described previously [36] . Dilution of were present as single bands, although for PKC-bII, d, and primary antibody solutions ranged from 1:1000 to 1:2500.´, two or three bands were detected on most blots. The The eight PKC isoforms tested were detected in this identity of these bands with respect to the positive control preparation (data not shown) with specific patterns of in each blot is described in more detail below. PKC cellular distribution as previously reported [33] [34] [35] . Jurkat expression was predominantly in the soluble fraction for cells, which were used as a positive control for the some isoforms (PKC-z and i), the particulate fraction for others (PKC-h and m), or both, with some variability stimulation which could activate or down-regulate PKC between specimens. A detailed analysis of isoform location prior to explant. The bands shown in Figs. 1-3 were was not undertaken, given the fact that specimens were eliminated by preincubation of primary antibody with the largely explanted from potential organ donors who were epitope peptide (peptide block) where appropriate. In maintained on life support and intravenous inotropes prior addition, Western analysis with a second panel of isoformto donation. Under such conditions, it is likely that hearts specific antibodies (column 2 of Table 1 ) detected bands of were subjected to a significant degree of neuro-hormonal similar size, which were also removed by peptide block. Taken together, these data indicate that the bands shown in In order to compare PKC isoform expression between Figs. 1-3 represent isoforms of PKC, with the exception of left and right ventricle, samples from both regions con-PKC-bII as described below. PKC-g and u were not taining identical amounts of protein (50 mg) were run detected when a twofold higher concentration of either together on the same gel (experiments replicated using four antibody or 100 mg of protein was used.
separate gels for each isoform). The results of these studies demonstrated that there was no obvious difference in This method was comparable to the addition of exogenous expression between the left and right ventricle for any of phosphatases such as PP1 or PP2A (data not shown). the PKC isoforms detected (data not shown).
Samples of human left ventricle before and following incubation at 308C were subjected to Western blotting 3.2. Phosphorylation of PKC isoforms using antibodies directed against PKC-bII, d, and´, with the results shown in Fig. 4B-D . In all three cases, It is known that PKC isoforms, including PKC-bII, are phosphatase activation led to an obvious enhancement of substrates for phosphorylation in vivo [40, 41] . To dethe lowest molecular weight band for each isoform (inditermine whether the multiple bands seen for PKC-bII, d, cated by the arrowheads at 78, 70, and 90 kDa for and´during Western analysis represented differentially PKC-bII, d, and´, respectively), particularly in the phosphorylated isoforms, experiments were performed to membrane fraction. This enhancement could be inhibited dephosphorylate PKC in vivo (n53 and n56 for nonby concomitant incubation with a combination of phosphadiseased and diseased hearts, respectively). Pilot experitase inhibitors (lanes 6 and 7), further confirming that it ments demonstrated that dephosphorylation of a radioresulted from dephosphorylation of PKC rather than 32 labelled substrate, [ P]glycogen phosphorylase a, was degradation. As illustrated in Figs. 1-3 as well as Fig. 4 , readily accomplished by incubation with human left venthese lower molecular weight bands were also present, and tricular homogenate at 308C for 1 h, which activates usually dominant, in the rat brain positive control, further endogenous phosphatases in the heart extract (Fig. 4A) .
confirming their identity as dephosphorylated species of the PKC isoforms. For PKC-d, the upper band at 74 kDa phorylated forms predominating in vivo under these condiminished in intensity with dephosphorylation. For PKCditions. , dephosphorylation led to the virtual disappearance of the upper band at 96 kDa, as well as the emergence of the 3.3. Antibody cross-reactivity and confirmation of PKC lower molecular weight band at 90 kDa (arrowhead), isoform expression which is also present in the rat brain positive control (also in Fig. 2 ). For PKC-bII, obvious change in the prominent
The experimental results using Western analysis are band at 83 kDa with dephosphorylation was not apparent, summarized in Table 2 , indicating molecular mass, presuggesting that it may not represent a form of PKC-bII. dominant site of expression, and the number of bands Thus with the possible exception of PKC-bII, the multiple detected for each isoform. Because of amino acid sequence bands detected by immunoblotting represent differentially homology between PKC isoforms, antibodies directed phosphorylated species of PKC-bII, d, and´, with phosagainst one isoform might cross-react with another, as PKC-i. Such cross-activity is less likely to occur with human heart samples due to the reduced quantity of PKC previously reported [27, 37] . In such cases, the pattern of present, compared with the amounts of recombinant endetection by immunoblotting should be identical for the zymes used in the experiments shown in Fig. 5 . Neverthetwo isoforms. With this concept in mind, the data presented less, to confirm expression of PKC-a, bI and z in human in Table 2 eliminate the possibility of antibody crossheart, reverse transcriptase-polymerase chain reaction (RT- PCR) using isoform-specific primers was performed using negative and positive controls, respectively, in each experitotal RNA from left ventricle (n53 for diseased hearts). ment. Bands of the appropriate size were detected in all The results are shown in Fig. 6 for three individual three specimens for PKC-a, bI, and z, consistent with specimens (ICM1, 2, and 3). In each case, RT-PCR was expression of these PKC isoforms in human left ventricle. performed in the presence (A) and absence (B) of DNase treatment, while RNA samples in the absence (C) and 3.4. PKC expression in cardiomyopathic states and the presence (D) of DNase which were not subjected to effect of sample preparation RT-PCR were run as controls. In addition, RNase-treated water (E) and samples probed with primers for the human To determine whether PKC isoform expression was 1 heart Na channel (F) were analyzed by RT-PCR as altered in the presence of disease states, immunoblotting was also performed on samples from patients with isdetected by Western analysis were also localized to venchemic cardiomyopathy (n57). The results are shown for tricular myocytes. In appropriate cases, incubation of the four patients with ischemic cardiomyopathy (ICM 1, 2, 3, antibody with epitope peptide eliminated isoform detection and 4) in Figs. 1-3 . Our results indicate that the same (data not shown). On the other hand, no staining was isoforms which are expressed in nondiseased heart are also observed for PKC-g or u, which were also absent by present in this pathologic state, with no evidence of an immunoblotting. While myocyte staining was present for isoform switch (i.e. pathologic expression of an isoform the PKC-bII antibody, this result must be interpreted with that was not detected in nondiseased tissue, and vice caution, given that the most prominent band detected versa).
during Western analysis at 83 kDa may not be PKC-bII, as Because of the small number of samples which were not discussed above. sex-matched (five nondiseased females and seven diseased males), we did not undertake a quantitative comparison to determine whether PKC isoform expression was either up-4. Discussion or down-regulated during cardiomyopathic states. However for a given specimen, variability in isoform expression was
In this study, we have investigated the molecular basis apparent when Western blot analysis was performed at for PKC isoform expression in nondiseased and diseased multiple time points following sample collection. The human ventricle. Using Western analysis, our results source of this variability was ultimately identified and is demonstrate a large number of isoforms normally present illustrated in Fig. 7 . Following explant, a portion of the left in left and right ventricle, including conventional, novel, ventricle for all hearts was subjected to immediate or acute and atypical types. To determine which PKC isoforms subcellular fractionation in the presence of protease indetected by Western blotting were present specifically in hibitors, while the remainder of the tissue was frozen in cardiac myocytes, immunohistochemistry was performed, liquid nitrogen until processed in an identical manner at a with the localization of all nine isoforms to this cell type. later date. In Fig. 7A , samples prepared acutely were This work represents the first comprehensive study of compared to samples from the same specimens which were PKC isoform expression in human ventricle, with utilizainitially frozen for a period of at least 12 months prior to tion of antibodies directed against all known PKC isosubcellular fractionation. It is apparent that expression of forms. It is known that PKC antibodies from different PKC-a is reduced in at least 2 of the specimens that were commercial sources vary widely in their properties, which frozen initially, indicative of protein degradation, commay account for discrepancies in previous reports of PKC pared to tissue processed acutely, despite equal amounts of expression in rat heart [27, 30] . For this reason, considerprotein present (as shown in Fig. 7B , which represents able effort was undertaken initially to identify antibodies ponceau staining of the same blot). This degradation was with optimal sensitivity and specificity, as described in the also apparent for PKC-bI, d,´, and i in our samples (data Methods. In addition, we established a rigorous set of not shown). In addition, evidence of PKC isoform degracriteria which had to be satisfied before an isoform was dation was also present in the normal specimen obtained at scored to be present, including detection of similar-sized autopsy, when it was compared to acutely prepared, bands by two different antibodies, ideally directed against explanted normal hearts (data not shown). These findings different epitopes, with appropriate peptide block and highlight the critical importance of sample preparation localization to cardiomyocytes. Potential antibody crosswhen comparing PKC isoform expression under different reactivity was identified, with confirmation of PKC isoconditions. form expression using RT-PCR. This exhaustive approach minimized errors in detection due to variability in antibody 3.5. Immunohistochemistry properties and allowed assignment of expression to cardiac myocytes. In previous studies of rat heart, PKC isoform expression Our experimental results suggest that human cardiac in pure populations of acutely-isolated ventricular myocytes express a greater variety of PKC isoforms than myocytes differed from isoform content of ventricular usually seen in other mammalian species. Numerous tissue homogenate, due to contamination of nonmyocyte investigations have focused on identification of the PKC elements in the latter preparation [1, 13, 21, 22, 24] . Similar isoforms in rat heart at various stages of development studies are difficult with human heart due to the very small [13, [21] [22] [23] [24] 26, 27, 30] . In studies of isolated, enriched popuproportion of viable myocytes obtained using cell disperlations of adult rat ventricular myocytes, there is general sion techniques [42, 43] . Therefore in order to identify agreement that PKC-d and´are present [21] , and probably which PKC isoforms were present specifically in human PKC-a and l as well [27, 30] . Some investigators have also ventricular myocytes, immunohistochemistry was peridentified the b isoforms [13, 44] . Additional studies in rat formed on tissue sections of left ventricle obtained from and other mammalian species have primarily used total three nondiseased and four diseased hearts as described ventricular homogenate for Western analysis. While PKC above. As demonstrated in Fig. 8 , all of the PKC isoforms isoform expression is more diverse under these circum- stance, there is also a greater contamination with nonFor human ventricle, our findings are in general agreemyocyte elements. Using this preparation for dog heart, the ment with the limited data available from previous studies. PKC-´and z isoforms have been detected, as well as Using Western blotting and immunohistochemistry, a possibly PKC-a and b [1, 29] . Similar investigations have recent report identified PKC-a, bI, bII, and´in nonfailing identified PKC-a,´and z in hamster [28] and 10 different and failing human left ventricle, while other isoforms were isoforms in rabbit [8, 10, 25] , while PKC-a,´, and z were not investigated [31] . Additional information has been detected in guinea pig heart [9] . Although not entirely derived from studies of tissue other than ventricle. In total comprehensive, these studies demonstrate the diversity of homogenate from adult human right atrium [45] , the a, d, PKC isoform expression in the heart. and´isoforms have been detected. On the other hand, Clerk et al.
[23] identified PKC-a,´, and z in total are normally not present, PKC-g and u, were not upreguventricular extract from human fetal (12-24 weeks) and lated in the remaining viable tissue. Thus although it is neonatal heart. well described that a number of fetal genes normally Our experimental results demonstrate that in ischemic absent in adult tissue can be turned on during disease cardiomyopathy, there was no evidence of an isoform processes such as hypertrophy [46, 47] , PKC-g and u are switch in PKC expression. In particular, isoforms which not targets of this gene expression paradigm.
